Active Ingredient: CARMUSTINE
Proprietary Name: GLIADEL
Dosage Form; Route of Administration: IMPLANT; INTRACRANIAL
Strength: 7.7MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N020637
Product Number: 001
Approval Date: Sep 23, 1996
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information